Back to Search
Start Over
Comparison of patient-reported outcomes among different types of oncoplastic breast surgery procedures.
- Source :
-
Journal of plastic, reconstructive & aesthetic surgery : JPRAS [J Plast Reconstr Aesthet Surg] 2022 Sep; Vol. 75 (9), pp. 3068-3077. Date of Electronic Publication: 2022 Apr 28. - Publication Year :
- 2022
-
Abstract
- Background: This study aims to compare patient-reported outcomes (PROs) after different types of oncoplastic surgery (OPS) procedures and correlate the results with previously published normative data from women with no prior history of breast cancer (BC) and breast surgery.<br />Methods: Cross-sectional study of patients with stage I-II BC undergoing a specific selection of OPS procedures from 04/2012 to 12/2018 by three breast surgeons at a single tertiary referral hospital in Switzerland. PROs were evaluated using the postoperative BREAST-Q questionnaire.<br />Results: One hundred twenty-seven patients met the inclusion criteria and were surveyed. All OPS techniques achieved comparably elevated scores in satisfaction with breasts, psychosocial, and sexual well-being. Compared to normative data of healthy women, all OPS groups postoperatively achieved significantly better satisfaction with breasts, psychosocial, and sexual well-being.<br />Conclusion: This study shows high PROs across all types of OPS, which were superior to normative data from healthy women. Our findings confirm that OPS is associated with high quality of life and patient satisfaction.<br />Competing Interests: Declaration of Competing Interest E. A. Kappos has received research support from the “Freiwillige Akademische Gesellschaft Basel”. W.P. Weber has received research support from Takeda Pharmaceuticals International via Swiss Group for Clinical Cancer Research (SAKK), honoraria/consultation from Genomic Health, Inc., USA, and support for conferences and meetings from Sandoz, Genomic Health, Medtronic, Novartis Oncology and Pfizer. J. Levy has received personal fees for his work by the Department of Breast Surgery, University Hospital of Basel. Kurzeder has received research support from Roche, Tessaro, Genomic Health, Pfizer, Astra Zeneca, GSK, and Lilly. All other authors have no conflict of interest to declare.<br /> (Copyright © 2022 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.)
Details
- Language :
- English
- ISSN :
- 1878-0539
- Volume :
- 75
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Journal of plastic, reconstructive & aesthetic surgery : JPRAS
- Publication Type :
- Academic Journal
- Accession number :
- 35732566
- Full Text :
- https://doi.org/10.1016/j.bjps.2022.04.051